Clinical Trials Logo

Diabete Type 2 clinical trials

View clinical trials related to Diabete Type 2.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06228911 Completed - Clinical trials for Osteoarthritis, Knee

Increased Blood Glucose Levels After Steroid Injection

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

a sample of 600 patients diagnosed as Knee osteoarthritis injected with 40 mg triamcinolone, recorded their morning fasting blood glucose levels for 7 days before injection used as the baseline blood glucose level, which was compared with FBS levels for 14 days after steroid injection. Our study compared the differences in blood glucose changes between HbA1c >7% and HbA1c ≤7% groups and those between insulin and non-insulin treated groups.

NCT ID: NCT06188572 Completed - Diabete Type 2 Clinical Trials

The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality

Start date: May 1, 2023
Phase:
Study type: Observational

The aim of this observational case-control study was to investigate the effect of diabetic peripheral neuropathy symptoms on temporomandibular joint functionality in patients with type 2 diabetes.

NCT ID: NCT05998525 Completed - Clinical trials for Diabetes Mellitus, Type 2

Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography

Start date: June 21, 2021
Phase: Phase 3
Study type: Interventional

Calcification of the coronary arteries is a direct sign of atherosclerotic disease of the coronary arteries and has been shown to be a strong predictor of the risk of cardiovascular diseases, including myocardial infarction and/or cardiac death, especially in patients with Diabetes Mellitus type 2. Therefore, there is great interest in pharmacotherapies that improve the rates of cardiovascular complications, and modify the outcomes of this group of patients. Large randomized controlled trials with SGLT2 inhibitors in patients with DM2 have shown a clear reduction in cardiovascular events among individuals with atherosclerotic disease. Atherosclerosis imaging allows measurable assessments of disease progression and activity, revealing early signs of potential drug effects. Noninvasive methods are preferred for serial imaging in drug trials due to the potential risks associated with invasive procedures. The coronary artery calcium quantification using the Agatston score is the most widely used method

NCT ID: NCT05904847 Completed - Diabete Type 2 Clinical Trials

The Effect of Theory-Based Education on Patient Empowerment and Self-Efficacy in Patients With Type 2 Diabetes

Start date: April 16, 2023
Phase: N/A
Study type: Interventional

It is essential to manage the disease to prevent and reduce complications and mortality in patients with diabetes. Adequate information and options should be provided to patients by healthcare providers so that patients can make informed choices. Patient education is a patient empowerment process designed to enable patients to be responsible for their health. With this study, it is considered essential to educate diabetic patients according to the theory of planned behavior and to develop self-efficacy by contributing to patient empowerment in this way.

NCT ID: NCT05789706 Completed - Diabetes Clinical Trials

Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans

Start date: March 24, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if a novel smartphone-based medication adherence platform accompanied by directed pharmacist intervention can improve A1c control and medication compliance in non-insulin dependent diabetics.

NCT ID: NCT05752929 Completed - Hyperglycemia Clinical Trials

Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients

CAPADOCIA1
Start date: January 1, 2016
Phase: Phase 4
Study type: Interventional

Hyperglycemia in the hospital is associated with multiple adverse outcomes. Previously, the mobile insulin scheme was used for its control. However, in the last decade, several studies have shown that the insulin basal-bolus (basal plus) regimen is associated with better glycemic control and a lower risk of hypoglycemia.

NCT ID: NCT05711602 Completed - Diabete Type 2 Clinical Trials

The Physical and Mental Health of People With Type II Diabetes Mellitus.

Start date: January 9, 2023
Phase: N/A
Study type: Interventional

To analyze the effects of a Pilates exercise program on physical and mental health in people with type II diabetes mellitus.

NCT ID: NCT05585268 Completed - Hypertension Clinical Trials

Electronic Decision Support for Deprescribing in Patients on Hemodialysis

MedSafer-HD
Start date: October 3, 2022
Phase: N/A
Study type: Interventional

Dialysis patients are prescribed an average of 10-12 medications per day, from up to 4-5 different clinicians and have the heaviest pill burden of all chronic conditions given their degree of comorbidity. One strategy for addressing the problem of "medication overload" is through scalable deprescribing interventions. MedSafer is an electronic deprescribing tool that cross-references patient health data with existing deprescribing guidelines and provides a deprescribing report to clinicians to facilitate deprescribing and reducing the burden of polypharmacy. In this study the investigators will test MedSafer on dialysis patients paired with medication reconciliation on an intervention unit compared to a control unit.

NCT ID: NCT05455242 Completed - Diabete Type 2 Clinical Trials

Habit Formation for Diabetes Self-Management

Start date: January 16, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the feasibility of interventions which focus on building habits as a method of improving diabetes self-management behaviors for individuals with type 2 diabetes.

NCT ID: NCT05413330 Completed - Cataract Clinical Trials

Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.

Start date: September 12, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators aim in this study to investigate the effect of intravitreal triamcinolone acetonide injection on the development of macular edema and the progression of diabetic retinopathy. Whether this injection hastens cataract surgery results or not. The investigators will categorize the participants into two groups: the case group who will receive the injection at the end of the surgery, and the control group who will have routine cataract surgery with no extra injections.